关注
Eishan Ashwat
Eishan Ashwat
University of Pittsburgh School of Medicine
在 pitt.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Treatment modalities and long-term outcomes of hepatic hemangioendothelioma in the United States
C Kaltenmeier, S Stacchiotti, A Gronchi, G Sapisochin, H Liu, E Ashwat, ...
HPB 24 (10), 1688-1696, 2022
72022
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer
H Liu, M D'Alesio, S AlMasri, A Hammad, A Desilva, S Lebowitz, C Rieser, ...
HPB 25 (5), 521-532, 2023
52023
Validation of the liver transplant risk score in Europe
E Ashwat, C Kaltenmeier, H Liu, D Reddy, A Thompson, S Dharmayan, ...
British Journal of Surgery 110 (3), 302-305, 2023
52023
Current status of living donor liver transplantation: impact, advantages, and challenges
H Liu, E Ashwat, A Humar
Current Gastroenterology Reports 25 (10), 225-231, 2023
42023
Outcomes of Radial Artery Versus Saphenous Vein as A Second Conduit After Coronary Artery Bypass Grafting
E Ashwat, JA Brown, S Yousef, D Ahmad, Y Wang, FW Thoma, ...
The American Journal of Cardiology 214, 33-39, 2024
12024
Function and longevity of renal grafts from high‐KDPI donors
M Molinari, C Kaltenmeier, H Liu, E Ashwat, D Jorgensen, C Puttarajappa, ...
Clinical Transplantation 36 (9), e14759, 2022
12022
748: DEFINING EFFECTIVE NEOADJUVANT CHEMOTHERAPY (NAC) IN PDAC, IMPLICATIONS FROM SURVIVAL AND PATTERN OF FAILURE IN PATIENTS WHO RECEIVED NAC
H Liu, M D'Alesio, S AlMasri, AY Hammad, A deSilva, C Rieser, E Ashwat, ...
Gastroenterology 162 (7), S-1331-S-1332, 2022
12022
Su1376: Higher hepatocellular carcinoma tumor burden score is associated with greater liver transplant survival benefit
H Liu, W Zhang, M Di, H Lee, R Cruz, X Wang, C Kaltenmeier, ...
Gastroenterology 162 (7), S-1198, 2022
12022
Acute Aortic Dissection After Transcatheter Aortic Valve Replacement
E Ashwat, D Ahmad, MP Sá, A Jackson, JA Brown, D Serna-Gallegos, ...
The American Journal of Cardiology 222, 108-112, 2024
2024
Donor-recipient race-ethnicity concordance and patient survival after liver transplantation
M Laffey, E Ashwat, H Lui, X Zhang, C Kaltenmeier, G Packiaraj, A Crane, ...
HPB 26 (6), 772-781, 2024
2024
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
S Leonard-Murali, C Bhaskarla, GS Yadav, SK Maurya, CR Galiveti, ...
Nature Communications 15 (1), 2863, 2024
2024
Radial artery vs right internal mammary artery as a second conduit during coronary artery bypass grafting
E Ashwat, JA Brown, S Yousef, D Ahmad, Y Wang, FW Thoma, ...
American Heart Journal 270, 44-54, 2024
2024
Liver retransplants using living donors: An approach for management
H Al Harakeh, C Hughes, A Tevar, V Gunabushanam, E Ashwat, H Liu, ...
Liver Research 7 (3), 252-255, 2023
2023
Author response to: Validation of the Liver Transplant Risk Score in Europe
M Molinari, E Ashwat
British Journal of Surgery 110 (2), 278-278, 2023
2023
HIGHER HEPATOCELLULAR CARCINOMA TUMOR BURDEN SCORE IS ASSOCIATED WITH GREATER LIVER TRANSPLANT SURVIVAL BENEFIT
H Liu, W Zhang, M Di, H Lee, R Cruz, X Wang, C Kaltenmeier, ...
GASTROENTEROLOGY 162 (7), S1198-S1198, 2022
2022
Defining Effective Neoadjuvant Chemotherapy (NAC) in PDAC, Implications from Survival and Pattern of Failure in Patients Who Received NAC
H Liu, M D'Alesio, S Al Masri, AY Hammad, A De Silva, E Ashwat, ...
ANNALS OF SURGICAL ONCOLOGY 29 (SUPPL 2), 386-386, 2022
2022
Stratification of Perioperative Mortality and Long-Term Survival in Liver Transplant Recipients at Listing: Validity of The Liver Transplant Risk Score (LTRS) in a European Cohort
E Ashwat, C Kaltenmeier, S Nadalin, O Ciccarelli, C Hughes, A Humar, ...
HPB 24, S31, 2022
2022
Neoadjuvant Chemotherapy Resulting in Suboptimal CA19-9 Response is Associated with No Survival Benefit Compared to Surgery First Approach in Resectable or Borderline …
H Liu, M D'Alesio, S Al Masri, A Hammad, A Desilva, E Ashwat, ...
HPB 24, S2-S3, 2022
2022
The Persistent Survival Gap of African American Undergoing Liver Transplantation for Stage II Hepatocellular Carcinoma in The United States
H Liu, C Kaltenmeier, E Ashwat, S Tohme, C Hughes, V Gunabushanam, ...
HPB 24, S566-S567, 2022
2022
The Effect of Donor-Recipient Race and Ethnicity Match on Liver Transplantation Outcome in The United States
H Liu, C Kaltenmeier, R Cruz, A Thompson, D Reddy, M D'Alesio, ...
HPB 24, S572, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20